Professor of drug regulatory scienceDutch Medicines Evaluation Board, Netherlands
Disclosure information not submitted.
Risk Minimization and Communication: Science-Based Approaches and Case Studies for Designing and Evaluating Effective Interventions for the Safe Use of Medicinal Products
Thursday, August 24, 20232:00 PM – 6:00 PM ADT
Leveraging Real-World Insights to Inform Long-term Follow-up for Cell and Gene Therapies: Opportunities for Pharmacoepidemiologists
Friday, August 25, 20233:30 PM – 5:00 PM ADT
